Multiprofile Hospital For Active Treatment Botevgrad Ltd.
- Address
- Blvd. Ul. Bozhko Bozhilov No 1, 2140 Botevgrad, Bulgaria
Multiprofile Hospital For Active Treatment Botevgrad Ltd.
Multiprofile Hospital For Active Treatment Botevgrad Ltd. is a comprehensive medical facility engaged in advanced cardiovascular research. The center specializes in Phase III clinical trials evaluating novel therapeutic approaches for patients with complex cardiac and renal conditions.
- Heart failure management with focus on combination therapies and cardiovascular outcomes
- Chronic kidney disease and cardiorenal syndrome research
- Cardiovascular mortality prevention and hospitalization reduction strategies
The hospital's research portfolio demonstrates expertise in investigating balcinrenone and dapagliflozin combination therapy for patients with chronic heart failure and impaired kidney function. Their clinical trials focus on improving outcomes for high-risk patients who have experienced recent heart failure events, with particular emphasis on reducing cardiovascular death and heart failure-related hospitalizations through innovative pharmacological interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB3active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Multiprofile Hospital For Active Treatment Botevgrad Ltd.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial | Metsera Inc. | Phase III | Not Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 2 | Unknown | 2024-07-12 | 2024-07-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.